If you would like us to provide educational information about Prolaris to your healthcare provider, include their information below
Genetic testing reveals what you can’t see but really want to know about prostate cancer, allowing patients and providers to make the best treatment decisions.
Prostate cancer prognostic test
Prostate cancer is personal and treatment should be too. Prolaris is for any untreated man with prostate cancer and helps patients and providers answer pressing clinical questions like:
I’m a patient
I’m a provider
You may have inherited more than just your eye color from your parents.
MyRisk is a genetic test that identifies mutations to determine if you have an inherited form of cancer. MyRisk helps qualify patients for new, personalized treatments – like targeted therapies and understand if you are at risk of developing a secondary cancer.
The complete suite of tests for a full prostate cancer workup
Myriad’s UroSuite gives health care providers the ability to directly order a complete suite of tests for comprehensive insights to guide prostate cancer treatment, including:
Myriad Genetics is the only lab to offer comprehensive testing across the spectrum of prostate cancer care, along with best-in-class support and specialists for you and your patients at every step.
Prolaris® is a molecular diagnostic test that helps determine the aggressiveness of a prostate cancer tumor to determine if a patient can safely watch their cancer in favor of active surveillance or if they should pursue treatment.
MyRisk is a germline test that offers a multi-gene panel to determine a patient’s risk of developing secondary cancers, as well as their children’s risk for the same germline mutations. MyRisk can also qualify patients for newer, personalized treatments such as targeted therapies and immunotherapy.
A somatic test that assesses 500+ genes, as well as key biomarkers like MSI, TMB and PD-L1, to determine if a patient’s tumor may be appropriate for novel therapies or clinical trials.
100% Medicare coverage for qualified patients
93% of patients pay $0
If you receive a bill and your expected out-of-pocket cost exceeds your budget, we have ways to help.
Prolaris Testing Guide
Understanding my Prolaris results
Understanding your PSA levels
Being a caregiver
Prostate cancer advocacy group
Prostate Cancer Symptoms and Treatment
Prolaris Test Request Form
Patient Record Request
Understanding the Prolaris report
Ask a genetic counselor
The Modern Urologist Podcast
Prolaris Technical Specifications
Prostate cancer is a very common disease, roughly 1 in 8 American men will be diagnosed with prostate cancer during their lifetime. Receiving a prostate…
SALT LAKE CITY, Aug. 15, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN) a leader …
Lisa’s mom’s battle with breast cancer inspired her to get genetic testing and make a life-saving choice. Her story is a testament to courage and resilience.
Navigate crucial prostate cancer treatment decisions – with the right answers at the right time.